● RESEARCH MATERIALS
Research-grade material sourcing with verified provenance, multi-stage analytical testing, and complete documentation for institutional and independent laboratory use.
Research-grade materials are manufactured using Solid-Phase Synthesis (SPPS) under controlled production conditions that ensure sequence accuracy, structural consistency, and batch-to-batch reproducibility. Each batch is produced according to documented synthesis protocols, with coupling efficiency monitored throughout the production process to verify sequence fidelity and minimize truncation artifacts.
Post-synthesis processing includes cleavage from the solid-phase resin, crude product analysis, and multi-stage purification through preparative HPLC. Final characterization confirms molecular identity through electrospray ionization mass spectrometry (ESI-MS) and verifies purity through analytical reverse-phase HPLC against validated reference standards.
END-TO-END SUPPLY CHAIN VERIFICATION
Research material supply chains require documented verification at each stage from synthesis through final delivery. Source qualification involves evaluation of manufacturing facilities, production methodologies, quality management systems, and historical analytical performance data. Vendor audits, certificate verification, and comparative batch analysis provide layered assurance that materials meet established specification requirements.
At GigaCompounds, supply chain integrity is maintained through long-term relationships with vetted synthesis facilities, independent analytical verification of every incoming batch, and documented chain-of-custody records from production through distribution. This multi-stage verification framework ensures that researchers receive materials with confirmed identity, verified purity, and complete traceability documentation.
Every batch of research material undergoes seven rounds of independent analytical testing through accredited third-party laboratories with no financial relationship to the supplier.
01
HPLC Purity
Reverse-phase chromatography quantification
02
Mass Spectrometry
ESI-MS molecular identity confirmation
03
Endotoxin Screening
LAL quantification below threshold
04
Sterility Testing
USP microbiological protocols
05
Amino Acid Analysis
Sequence composition verification
06
Residual Solvents
ICH guideline compliance
07
Net Content
Active material quantification
Complete test results are documented in Certificates of Analysis (COAs) maintained through the institutional batch verification workflow.
Research-grade materials are supplied in lyophilized form to maximize storage stability and shelf life. Lyophilization removes residual moisture under controlled vacuum conditions, producing a stable powder that resists degradation pathways including hydrolysis, oxidation, and microbial contamination. Lyophilized materials should be stored at -20°C for long-term preservation or at 2–8°C for short-term laboratory use.
Reconstitution protocols vary by solubility profile. Most research-grade materials reconstitute readily in bacteriostatic water or sterile saline solutions. Reconstituted preparations should be stored at 2–8°C, protected from light, and used within documented stability windows.
GigaCompounds supports institutional procurement through documented ordering processes, batch-specific COA delivery, and structured communication channels for research facility purchasing departments. All releases include complete documentation, batch identification, and analytical verification records suitable for institutional record-keeping and compliance documentation.
Same-day processing is available for institutional requests received before the daily fulfillment cutoff. Research facilities requiring custom documentation, bulk quantities, or specialized packaging configurations may contact the research support team for tailored procurement workflows.
Research Use Only. All materials referenced on this page are supplied solely for laboratory and research use. They are not intended for human or animal consumption, clinical use, diagnostic use, or therapeutic application. Statements have not been evaluated by the FDA.
